Ferucarbotran (Resovist) is the second clinically approved superparamagnetic iron oxide
developed for contrast-enhanced MRI of the liver. The purpose of this review is to provide an …

Superparamagnetic iron oxide (SPIO) particles are a potent new class of MR contrast agents
affording improved detection of hepatic and splenic neoplasms. In this report we review the …

A newly developed non-polymer coated Fe3O4 nanoparticles showing well-dispersion were
synthesized using Fe (II) and Fe (III) salt chemical coprecipitation with tetramethylammonium …

Biocompatible ferrofluid based on dextran-coated Fe3O4 magnetic nanoparticles (MNPs)
was prepared through a one-step method. In contrast to the conventional co-precipitation …

Superparamagnetic iron oxide nanoparticles (SPIO) can be used to image physiological
processes and anatomical, cellular and molecular changes in diseases. The clinical …

PURPOSE: To assess the safety and diagnostic efficacy of intravenous ferumoxides, a
superparamagnetic iron oxide, for depiction of focal hepatic lesions on magnetic resonance …

A new nanoparticulate inorganic− organic hybrid-type positive contrast agent (CA),
PGP/dextran-K01, was synthesized based on a GdPO4 inorganic core as a relaxation-time …

A variety of parenterally administered iron oxides have been developed for contrast-
enhanced MRI of the liver. Two different classes of iron oxides are currently clinically …

Alzheimer's disease (AD) is the most prevalent age-related neurodegenerative disease,
pathologically characterized by the accumulation of aggregated amyloid beta (Aβ) in the …

PURPOSE: To compare the sensitivities of superparamagnetic iron oxide-enhanced and
unenhanced magnetic resonance (MR) imaging at 1.5 T with those of percutaneous …